Health Trials

Patients With Chemotherapy-Induced Thrombocytopenia

1

Review clinical trials related to Patients With Chemotherapy-Induced Thrombocytopenia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

The study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.

Participants needed: 150
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Jiangsu HengRui Medicine Co., Ltd.Updated: Apr 30, 2026Locations: 7
Eligibility criteria

Male or female gender, age ≥18 years at screening. [+5]

Hematopoietic diseases other than CIT (e.g., primary immune thrombocytopenia). [+10]

Read more